Cardiovascular effects of phosphodiesterase type 5 inhibitors
C Vlachopoulos, N Ioakeimidis… - The Journal of …, 2009 - academic.oup.com
ABSTRACT Introduction Phosphodiesterase type 5 (PDE5) inhibitors are widely used as first-
line therapy for erectile dysfunction (ED). Their efficacy and safety combined with an …
line therapy for erectile dysfunction (ED). Their efficacy and safety combined with an …
[引用][C] Cardiovascular Effects of Phosphodiesterase Type 5 Inhibitors
C Vlachopoulos, N Ioakeimidis, K Rokkas… - Journal of Sexual …, 2009 - hero.epa.gov
Cardiovascular Effects of Phosphodiesterase Type 5 Inhibitors | Health & Environmental
Research Online (HERO) | US EPA Jump to main content US EPA United States …
Research Online (HERO) | US EPA Jump to main content US EPA United States …
Cardiovascular effects of phosphodiesterase type 5 inhibitors.
C Vlachopoulos, N Ioakeimidis, K Rokkas… - The Journal of Sexual …, 2008 - europepmc.org
Aim To review and discuss recent findings regarding the cardiovascular effects of PDE5
inhibitors and to highlight current and future clinical applications beyond ED. Main outcome …
inhibitors and to highlight current and future clinical applications beyond ED. Main outcome …
[引用][C] Cardiovascular Effects of Phosphodiesterase Type 5 Inhibitors
C Vlachopoulos, N Ioakeimidis, K Rokkas… - The Journal of Sexual …, 2009 - cir.nii.ac.jp
Cardiovascular Effects of Phosphodiesterase Type 5 Inhibitors | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
Cardiovascular Effects of Phosphodiesterase Type 5 Inhibitors
C Vlachopoulos, N Ioakeimidis, K Rokkas… - The Journal of Sexual …, 2009 - Elsevier
ABSTRACT Introduction Phosphodiesterase type 5 (PDE5) inhibitors are widely used as first-
line therapy for erectile dysfunction (ED). Their efficacy and safety combined with an …
line therapy for erectile dysfunction (ED). Their efficacy and safety combined with an …
Cardiovascular effects of phosphodiesterase type 5 inhibitors
C Vlachopoulos, N Ioakeimidis… - The journal of …, 2009 - pubmed.ncbi.nlm.nih.gov
Introduction Phosphodiesterase type 5 (PDE5) inhibitors are widely used as first-line therapy
for erectile dysfunction (ED). Their efficacy and safety combined with an increasing …
for erectile dysfunction (ED). Their efficacy and safety combined with an increasing …
Cardiovascular Effects of Phosphodiesterase Type 5 Inhibitors
C Vlachopoulos, N Ioakeimidis… - The Journal of …, 2009 - Wiley Online Library
ABSTRACT Introduction. Phosphodiesterase type 5 (PDE5) inhibitors are widely used as
first‐line therapy for erectile dysfunction (ED). Their efficacy and safety combined with an …
first‐line therapy for erectile dysfunction (ED). Their efficacy and safety combined with an …